Back
Cogent Biosciences Vs. Akero Therapeutics Industry Stock Comparison
Sell
50
COGT
Cogent Biosciences
Last Price:
8.61
Seasonality Move:
-25.57%
Buy
75
AKRO
Akero Therapeutics
Last Price:
19.87
Seasonality Move:
2.55%
Sell
50
Cogent Biosciences (COGT)
is a Sell
Is Cogent Biosciences a Buy, Sell or Hold?
- The current Cogent Biosciences [COGT] share price is $8.64. The Score for COGT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- COGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.87. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COGT Stock Price Chart
What is Cogent Biosciences's stock price today?
-
The Cogent Biosciences share price today is $8.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COGT is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.87
The current trend is relatively stagnant and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
COGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 58.87 | Buy |
Chaikin Money Flow: | -1168517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.93 - 8.33) | Buy |
Bollinger Bands (100): | (8.15 - 12.03) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 62.82 | Buy |
Chaikin Money Flow: | 856236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.51 - 17.91) | Buy |
Bollinger Bands (100): | (17.18 - 49.32) | Sell |
COGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.21 | Buy |
20-day SMA: | 7.55 | Buy |
50-day SMA: | 8.4 | Buy |
200-day SMA: | 10.87 | Sell |
8-day EMA: | 8.24 | Buy |
20-day EMA: | 7.95 | Buy |
50-day EMA: | 8.52 | Buy |
200-day EMA: | 10.4 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.24 | Buy |
20-day SMA: | 16.58 | Buy |
50-day SMA: | 19.62 | Buy |
200-day SMA: | 38.97 | Sell |
8-day EMA: | 18.47 | Buy |
20-day EMA: | 17.44 | Buy |
50-day EMA: | 21.56 | Sell |
200-day EMA: | 33.86 | Sell |
Cogent Biosciences Earnings Growth & COGT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.10 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Cogent Biosciences Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | Dec 7 | Dec 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | Dec 7 | Dec 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |